
Quotient Limited QTNT
Quarterly report 2022-Q4
added 02-09-2023
Quotient Limited P/CF Ratio 2011-2026 | QTNT
Annual P/CF Ratio Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.36 | -7.78 | -5.72 | -1.89 | -2.51 | -2.71 | -4.14 | -11.2 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.89 | -11.2 | -4.78 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
28.3 | $ 118.56 | -1.01 % | $ 36 B | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 21.73 | 5.69 % | $ 234 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 525.86 | 1.41 % | $ 15.2 B | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 22.35 | 27.21 % | $ 1.19 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
NeoGenomics
NEO
|
284 | $ 8.15 | -6.16 % | $ 1.04 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.2 | -2.39 % | $ 2 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 28.87 | -0.76 % | $ 20 B | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.46 | 2.82 % | $ 1.94 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 24.42 | -0.81 % | $ 678 M | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 6.79 | -1.59 % | $ 283 M | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 52.59 | 0.03 % | $ 2.67 B | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Neuronetics
STIM
|
-3.98 | $ 1.39 | -0.36 % | $ 91.7 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 180.18 | -0.21 % | $ 8.93 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 519.83 | -2.23 % | $ 196 B | ||
|
Danaher Corporation
DHR
|
23.3 | $ 194.25 | -1.96 % | $ 138 B | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 2.2 | - | $ 9.73 M | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 0.69 | -1.42 % | $ 61.9 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 56.23 | -2.41 % | $ 3.36 B | ||
|
Illumina
ILMN
|
19.6 | $ 131.79 | -0.36 % | $ 21 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 16.13 | -0.25 % | $ 488 M | ||
|
Guardant Health
GH
|
-72.7 | $ 84.99 | 0.15 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-0.0144 | $ 2.81 | -4.09 % | $ 91.2 K | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.19 | 4.03 % | $ 5.03 M | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 118.16 | 1.42 % | $ 9.75 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 268.19 | 0.48 % | $ 22.3 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
30.1 | $ 321.65 | -1.4 % | $ 19.2 B | ||
|
Celcuity
CELC
|
-35 | $ 124.49 | 0.82 % | $ 5.82 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 5.1 | -1.76 % | $ 472 M | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 82.61 | -1.58 % | $ 5.58 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 192.76 | 0.7 % | $ 21.4 B |